Due to the abundance of vector Aedes aegypti and the constant circulation of the 1, 2, 4 serotypes, Yucatan, Mexico, is a dengue endemic region. In 2015, chikungunya virus (CHIKV) infection was common because the population was immunologically naive (
1). During the CHIKV outbreak in Yucatan, all samples from clinically suspected cases were confirmed and samples from ambulatory patients were randomly selected to be confirmed by laboratory tests.
The occurrence of clinical diagnostic mistakes is described both in endemic areas and during outbreak seasons, in which the agent associated with the outbreak is usually suspected to be the etiologic factor of every similar case. In Yucatan, an unpredicted increase in dengue cases also took place simultaneously with CHIKV outbreak. The characterization of the clinical manifestations of chikungunya and dengue are similar and might represent a diagnostic challenge to clinicians practicing in endemic regions during outbreak seasons. It is important to properly identify the etiologic nature of the disease, since chikungunya and dengue have different clinical spectrum and prognosis, while dengue is more prone to generate hemorrhagic manifestations in the short-term, chikungunya might develop a prolonged arthritis-like pain and disability. In Mexico, since the national standard epidemiologic procedures do not allow an acute sample to be tested for both dengue and chikungunya, clinicians must rely on their experience to define which of those agents should be confirmed or discarded by laboratory (if randomly selected). CHIKV generates a febrile illness in most people with an incubation period of 2 to 4 days after being bitten by Aedes mosquitoes. There is also affectation of the mayor joints such as the knee, shoulder, and vertebral spine. The current case series study compared the clinical manifestations in ambulatory patients whose samples were processed in the laboratory and according to their test results signs and symptoms that might aid during clinical differential diagnosis were identified (
2-
4).
CHIKV cases can be categorized as confirmed, discarded, and suspected. The confirmed cases are the ones with a positive result to CHIKV by any of the following laboratory tests: 1, Detection of viral ribonucleic acid (RNA) by reverse transcription polymerase chain reaction (RT-PCR) in serum samples taken in the first 5 days; 2, Detection of IgM antibodies in paired samples. An increase of at least 4 times in the antibody titer for chikungunya fever should be noted with a difference of at least 1 week between the first and second sample; 3, Detection of IgG antibodies in paired serum sample. An increase of at least 4 times in the antibody titers should be noted with a difference of at least 1 week between the first and the second. Discarded cases are the ones in which the presence of virus or specific antibodies (depending on the time elapsed since the onset of symptoms) is not demonstrated. Finally, the suspected cases consist of fever with arthritis and arthralgia reported in the areas where transmission of CHIKV is confirmed (
5,
6).